Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) price is hovering higher on current market day and jumping 67.64% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $1.73, with intraday deals fluctuating between $2.2001 and $3.5. The company’s 5Y monthly beta was ticking 0.719. Taking into account the 52-week price action we note that the stock hit a 52-week high of $23.80 and 52-week low of $1.67. The stock added 14.88% on its value in the past month.
Galmed Pharmaceuticals Ltd, which has a market valuation of $4.79 million, is expected to release its quarterly earnings report on 2024-Apr-03.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give GLMD a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 7 analysts have assigned GLMD a recommendation rating as follows: 3 rate it as a Hold; 4 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Galmed Pharmaceuticals Ltd (GLMD) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that GLMD’s price is at present 32.26% off the SMA20 and 12.76% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 65.34, with weekly volatility standing at 10.43%. The indicator jumps to 10.16% when calculated based on the past 30 days. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)’s beta value is holding at 0.63, while the average true range (ATR) indicator is currently reading 0.32.
An analysis of the Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock in terms of its daily trading volume indicates that the 3-month average is 32.65K. However, this figure increases on the past 10-day timeline to an average of 41810.0.
Current records show that the company has 1.66M in outstanding shares. The insiders’ percentage holdings are 1.72% of outstanding shares while the percentage share held by institutions stands at 12.80%. The stats also highlight that short interest as of 2025-02-28, stood at 4859.0 shares, which puts the short ratio at the time at 0.26. From this we can glean that short interest is 30.00 of company’s current outstanding shares. Notably, we see that shares short in February fall slightly given the previous month’s figure stood at 6825.0. But the -9.25% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
